Role of p16(INK4A) in detection of human papillomavirus DNA and stratification of cancer-specific mortality on the basis of long term follow-up data of 34 patients with invasive penile cancer
Aktuelle Urol. 2018; Bründl J, Neppl C, Hommer T, Otto W, Breyer J, Brookman-May S, Weber F, Burger M, May M, Eichelberg C
Management of penile cancerpatients: newaspects of a rare tumour entity
Aktuelle Urol. 2018;49(3): 242-249; Roiner M, Maurer O, Lebentrau S, Gilfrich C, Schäfer C, Haberl C, Brookman-May SD, Burger M, May M, Hakenberg OW
Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study
BJU Int. 2018;121(1): 101-110; Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, FritscheHM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A, PROMETRICS 2011 Study Group , Bartsch G, Bolenz C, Brookman-May S, Buchner A, Durschnabel M, Ellinger J, Froehner M, Georgieva G, Gilfrich C, Gördük M, Grimm MO, Hadaschik B, Haferkamp A, Hartmann F, Herrmann E, Hertle L, Hohenfellner M, Janetschek G, Keck B, Kraischits N, Krausse A, Lusuardi L, Martini T, Michel MS, Moritz R, Müller SC, Novotny V, Pahernik S, Palisaar RJ, Ponholzer A, Roigas J, Schmid M, Schramek P, Seitz C, Sikic D, Stief CG, Syring I, Traumann M, Vallo S, Wagenlehner FM, Weidner W, Wirth MP, Wullich B
The World Health Organization1973classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer
BJU Int. 2018;122(6): 978-985; van de Putte EEF, Bosschieter J, van der Kwast TH, Bertz S, Denzinger S, Manach Q, Compérat EM, Boormans JL, Jewett MAS, Stoehr R, van Leenders GJLH, Nieuwenhuijzen JA, Zlotta AR, Hendricksen K, Rouprêt M, Otto W, Burger M, Hartmann A, van Rhijn BWG
Expression, localisation and potentialsignificance of aquaporins in benign and malignant human prostate tissue
BMC Urol. 2018;18(1): 75; Bründl J, Wallinger S, Breyer J, Weber F, Evert M, Georgopoulos NT, Rosenhammer B, Burger M, Otto W, Rubenwolf P
HighPDL1mRNAexpression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients
Cancer Immunol Immunother. 2018;67(3): 403-412; Breyer J, Wirtz RM, Otto W, Erben P, Worst TS, Stoehr R, Eckstein M, Denzinger S, Burger M, Hartmann A
HighCDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma
Clin Genitourin Cancer. 2018;16(4): 248-256.e2; Breyer J, Wirtz RM, Erben P, Worst TS, Stoehr R, Eckstein M, Bertz S, Sikic D, Denzinger S, Burger M, Hartmann A, Otto W, Bladder Cancer Research Initiative for Drug Targets Germany (BRIDGE) Consortium eV, Mannheim, Germany, Breyer J, Wirtz RM, Erben P, Worst TS, Stoehr R, Eckstein M, Sikic D, Burger M, Hartmann A, Otto W
Influence of Gender and Age on the Willingness to Reduce Nicotine Consumption-Results of a Survey in Urological Cancer Patients (KRAUT Study)
Clin Genitourin Cancer. 2018;16(6): e1181-e1187; Dombrowski M, May M, Spachmann PJ, Ganesh Kumar M, Fritsche HM, Brookman-May S, Maurer O, Burger M, Gilfrich C
T1High-gradeBladder Cancer: The Search for the Optimal Management Continues
Eur Urol. 2018;74(5): 609-610; Mostafid H, Palou J, Burger M, Babjuk M
EuropeanAssociation of UrologyGuidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
Eur Urol. 2018;73(1): 111-122; Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Gontero P, Van Rhijn BWG, Mostafid AH, Palou J, Shariat SF
Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?
Eur Urol Focus. 2018;4(4): 525-528; Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid HA, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Dominguez-Escrig JL, Hernández V, Peyronnet B, Seisen T, Soukup V, European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer
Training, Research, and Working Conditions for UrologyResidents in Germany: A Contemporary Survey
Eur Urol Focus. 2018;4(3): 455-460; Borgmann H, Arnold HK, Meyer CP, Bründl J, König J, Nestler T, Ruf C, Struck J, Salem J
Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016"
Eur Urol Focus. 2018; Compérat EM, Burger M, Gontero P, Mostafid AH, Palou J, Rouprêt M, van Rhijn BWG, Shariat SF, Sylvester RJ, Zigeuner R, Babjuk M
Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel
Eur Urol Focus. 2018; Soukup V, Capoun O, Cohen D, Hernández V, Burger M, Compérat E, Gontero P, Lam T, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Yuan Y, Zigeuner R, Babjuk M
Effectiveness of Adjuvant ChemotherapyAfterRadicalCystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis
Eur Urol Focus. 2018;4(2): 252-259; Vetterlein MW, Seisen T, May M, Nuhn P, Gierth M, Mayr R, Fritsche HM, Burger M, Novotny V, Froehner M, Wirth MP, Protzel C, Hakenberg OW, Roghmann F, Palisaar RJ, Noldus J, Pycha A, Bastian PJ, Trinh QD, Xylinas E, Shariat SF, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A, PROMETRICS 2011 Study Group
Highproliferationrate and TNM-stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma
Hum Pathol. 2018; Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stöckle M, Becker F, Ströbel P, Wülfing C, Schrader AJ, Barth P, Staehler M, Stief C, Hohenfellner M, Macher-Göppinger S, Höfler H, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Haferkamp A, Geppert CI, Stöhr C, Hartmann A, German Network Of Kidney Cancer
Long-termoutcomeaftergrafting with small intestinalsubmucosa and collagen fleece in patients with Peyronie's disease: a matched pair analysis
Int J Impot Res. 2018; Rosenhammer B, Sayedahmed K, Fritsche HM, Burger M, Kübler H, Hatzichristodoulou G
mRNA-Expression of KRT5 and KRT20DefinesDistinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants
Int J Mol Sci. 2018;19(11); Eckstein M, Wirtz RM, Gross-Weege M, Breyer J, Otto W, Stoehr R, Sikic D, Keck B, Eidt S, Burger M, Bolenz C, Nitschke K, Porubsky S, Hartmann A, Erben P
Infiltrativelamina propriainvasionpattern as an independent predictor for cancer-specific and overall survival of instillation treatment-naive stage T1 high-grade urothelial bladder cancer
Int J Urol. 2018;25(5): 442-449; Otto W, van Rhijn BW, Breyer J, Bertz S, Eckstein M, Mayr R, Lausenmeyer EM, Denzinger S, Burger M, Hartmann A
What do patients with urothelialcancer know about the association of their tumor disease with smoking habits? Results of a German survey study
Investig Clin Urol. 2018;59(2): 91-97; May M, Fritsche HM, Gilfrich C, Dombrowski M, Maurer O, Spachmann P, Kumar MG, Bjurlin M, Burger M, Brookman-May S
Sarcopenia as a comorbidity-independentpredictor of survival following radical cystectomy for bladder cancer
J Cachexia Sarcopenia Muscle. 2018;9(3): 505-513; Mayr R, Gierth M, Zeman F, Reiffen M, Seeger P, Wezel F, Pycha A, Comploj E, Bonatti M, Ritter M, van Rhijn BWG, Burger M, Bolenz C, Fritsche HM, Martini T
Codon72Polymorphism and Risk for Squamous CellCarcinoma of the Penis: A Caucasian Case-ControlStudy
J Cancer. 2018;9(22): 4234-4241; Stoehr R, Weisser R, Wendler O, Giedl J, Daifalla K, Gaisa NT, Richter G, Campean V, Burger M, Wullich B, Hartmann A
FOXM1predictsdisease progression in non-muscleinvasivebladder cancer
J Cancer Res Clin Oncol. 2018;144(9): 1701-1709; Rinaldetti S, Wirtz R, Worst TS, Hartmann A, Breyer J, Dyrskjot L, Erben P
ProspectiveEvaluation of PredictiveParameters for Urinary Tract Infection in Patients with Acute Renal Colic
J Emerg Med. 2018;55(3): 319-326; Rosenhammer B, Spachmann PJ, Burger M, Fritsche HM, Schnabel MJ
Diagnosis, Treatment, and Outcome of Arterioureteral Fistula: The Urologist's Perspective
J Endourol. 2018;32(3): 245-251; Heers H, Netsch C, Wilhelm K, Secker A, Kurtz F, Spachmann P, Viniol S, Hofmann R, Hegele A
Improvedprediction of nephron-sparingsurgeryversusradical nephrectomy by the optimized R.E.N.A.L. (optR.E.N.A.L.) score in patients undergoing surgery for renal masses
Minerva Urol Nefrol. 2018; Sterzik A, Solyanik O, Eichelberg C, Jost M, Graser A, Lausenmeyer EM, Otto W, Waidelich R, Stief CG, Burger M, May M, Brookman-May SD
Differentiation-associatedurothelial cytochrome P450 oxidoreductase predicates the xenobiotic-metabolizing activity of "luminal" muscle-invasive bladder cancers
Mol Carcinog. 2018;57(5): 606-618; Baker SC, Arlt VM, Indra R, Joel M, Stiborová M, Eardley I, Ahmad N, Otto W, Burger M, Rubenwolf P, Phillips DH, Southgate J
A multicenterroundrobintest of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy
Oncotarget. 2018;9(19): 15001-15014; Eckstein M, Wirtz RM, Pfannstil C, Wach S, Stoehr R, Breyer J, Erlmeier F, Günes C, Nitschke K, Weichert W, Otto W, Keck B, Eidt S, Burger M, Taubert H, Wullich B, Bolenz C, Hartmann A, Erben P
CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making
Sci Rep. 2018;8(1): 14383; Worst TS, Weis CA, Stöhr R, Bertz S, Eckstein M, Otto W, Breyer J, Hartmann A, Bolenz C, Wirtz RM, Erben P
PrognosticValue of MolecularBreast CancerSubtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer
Transl Oncol. 2018;11(2): 467-476; Kriegmair MC, Wirtz RM, Worst TS, Breyer J, Ritter M, Keck B, Boehmer C, Otto W, Eckstein M, Weis CA, Hartmann A, Bolenz C, Erben P
Accordance of OnlineHealthInformation on Prostate Cancer with the European Association of Urology Guidelines
Urol Int. 2018;100(3): 288-293; Bruendl J, Rothbauer C, Ludwig B, Dotzler B, Wolff C, Reimann S, Borgmann H, Burger M, Breyer J
Influence of Body Mass Index on ClinicalOutcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study
Urol Int. 2018;101(1): 16-24; Gierth M, Zeman F, Denzinger S, Vetterlein MW, Fisch M, Bastian PJ, Syring I, Ellinger J, Müller SC, Herrmann E, Gilfrich C, May M, Pycha A, Wagenlehner FM, Vallo S, Bartsch G, Haferkamp A, Grimm MO, Roigas J, Protzel C, Hakenberg OW, Fritsche HM, Burger M, Aziz A, Mayr R
Holmium LaserEnucleation of the ProstateProvidesSimilar Incidental Prostate Cancer Detection Rates as Open Prostatectomy: A Matched Pair Analysis
Urol Int. 2018;101(4): 382-386; Rosenhammer B, Lausenmeyer EM, Mayr R, Burger M, Eichelberg C
Metricsubstageaccording to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer
Urol Oncol. 2018;36(8): 361.e7-361.e13; Fransen van de Putte EE, Otto W, Hartmann A, Bertz S, Mayr R, Bründl J, Breyer J, Manach Q, Compérat EM, Boormans JL, Bosschieter J, Jewett MAS, Stoehr R, van Leenders GJLH, Nieuwenhuijzen JA, Zlotta AR, Hendricksen K, Rouprêt M, Burger M, van der Kwast TH, van Rhijn BWG
The prognosticeffect of salvagesurgery and radiotherapy in patients with recurrent primary urethral carcinoma
Urol Oncol. 2018;36(1): 10.e7-10.e14; Gakis G, Schubert T, Morgan TM, Daneshmand S, Keegan KA, Mischinger J, Clayman RH, Brisuda A, Ali-El-Dein B, Galland S, Gregg J, Balci M, Olugbade K, Rink M, Fritsche HM, Burger M, Babjuk M, Stenzl A, Thalmann GN, Kübler H, Efstathiou JA
Erratum to 'Predictivevalue of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy' [Urologic Oncology: Seminars and Original Investigations 36/12 (2018) 505-534]
Urol Oncol. 2018; Martini T, Heinkele J, Mayr R, Weis CA, Wezel F, Wahby S, Eckstein M, Schnöller T, Breyer J, Wirtz R, Ritter M, Bolenz C, Erben P
Predictivevalue of lymphangiogenesis and proliferationmarkers on mRNAlevel in urothelial carcinoma of the bladder after radical cystectomy
Urol Oncol. 2018;36(12): 530.e19-530.e27; Martini T, Heinkele J, Mayr R, Weis CA, Wezel F, Wahby S, Eckstein M, Schnöller T, Breyer J, Wirtz R, Ritter M, Bolenz C, Erben P
p53-expression in patients with renal cell carcinomacorrelates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models
Urol Oncol. 2018;36(3): 94.e15-94.e21; Morshaeuser L, May M, Burger M, Otto W, Hutterer GC, Pichler M, Klatte T, Wild P, Buser L, Brookman-May S
Impact of surgeon's experience on outcome parameters following ureterorenoscopic stone removal
Urolithiasis. 2018; Wolff I, Lebentrau S, Miernik A, Ecke T, Gilfrich C, Hoschke B, Schostak M, May M, BUSTER study group , Baars A, Balsmeyer U, Burger M, de Boer MC, Danzer G, Enzmann T, Fahlenkamp D, Filter S, Fritsche HM, Hallmann S, Hebert J, Huber T, Lehsnau M, Müller PF, Peter J, Porsch M, Promnitz S, Rodat M, Schmidt W, Schoeneich F, Schoenthaler M, Weikert S, Werthemann P, Ziegler H
Imaging in individualizeduro-oncology
Urologe A. 2018;57(9): 1048-1057; Bründl J, Breyer J, Burger M
Molecularcharacterization of penile cancer: Literature review of new prognostic markers and potential therapeutic targets
Urologe A. 2018;57(4): 398-407; May M, Brookman-May SD, Ecke TH, Burger M
Interraterreliability and clinicalimpact of the Post-Ureteroscopic Lesion Scale (PULS) grading system for ureteral lesions after ureteroscopy: Results of the German prospective multicenter BUSTER project
Urologe A. 2018;57(2): 172-180; May M, Schönthaler M, Gilfrich C, Wolff I, Peter J, Miernik A, Fritsche HM, Burger M, Schostak M, Lebentrau S, BUSTER-Arbeitsgruppe , Baars A, Balsmeyer U, Burger M, de Boer MC, Danzer G, Ecke T, Enzmann T, Fahlenkamp D, Filter S, Fritsche HM, Gilfrich C, Hallmann S, Hebert J, Hoschke B, Huber T, Lebentrau S, Lehsnau M, May M, Miernik A, Mueller PF, Peter J, Porsch M, Promnitz S, Rodat M, Schmidt W, Schoeneich F, Schoenthaler M, Schostak M, Weikert S, Werthemann P, Wolff I, Ziegler H
Analysis of the prognosticrelevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder
Virchows Arch. 2018; Erben P, Sikic D, Wirtz RM, Martini T, Weis CA, Breyer J, Otto W, Keck B, Hartmann A, Bolenz C, BRIDGE Consortium e.V., Erben P, Sikic D, Wirtz RM, Martini T, Breyer J, Otto W, Keck B, Hartmann A, Bolenz C
Multicenterevaluation of guideline adherence for pelviclymph node dissection in patients undergoing open retropubic vs. laparoscopic or robot assisted radical prostatectomy according to the recent German S3 guideline on prostate cancer
World J Urol. 2018;36(6): 855-861; BorkowetzA, Bruendl J, Drerup M, Herrmann J, Isbarn H, Beyer B, GeSRU Academics Prostate Cancer Group
Wake-upcall for more doctor-patient communication and an increase in public information campaigns on the risk factor of smoking with regard to the development and prognosis of bladder cancer
World J Urol. 2018; Gilfrich C, Maurer O, Spachmann PJ, Dombrowski MK, Burger M, May M
Hospitalvolume in ureterorenoscopicstonetreatment: 99 operations per year could increase the chance of a better outcome-results of the German prospective multicentre BUSTER project
World J Urol. 2018; Lebentrau S, Enzmann T, Lehsnau M, Christoph F, Schostak M, May M, BUSTER study group , Baars A, Balsmeyer U, Burger M, de Boer MC, Danzer G, Ecke T, Enzmann T, Fahlenkamp D, Filter S, Fritsche HM, Gilfrich C, Hallmann S, Hebert J, Hoschke B, Huber T, Lebentrau S, Lehsnau M, May M, Miernik A, Müller PF, Peter J, Porsch M, Promnitz S, Rodat M, Schmidt W, Schoeneich F, Schoenthaler M, Schostak M, Weikert S, Werthemann P, Wolff I, Ziegler H
Sarcopeniapredicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer
World J Urol. 2018;36(8): 1201-1207; Mayr R, Fritsche HM, Zeman F, Reiffen M, Siebertz L, Niessen C, Pycha A, van Rhijn BWG, Burger M, Gierth M
HoLEPprovides a higherprostate cancer detection rate compared to bipolar TURP: a matched-pair analysis
World J Urol. 2018;36(12): 2035-2041; Rosenhammer B, Lausenmeyer EM, Mayr R, Burger M, Eichelberg C
Kontakt
Terminvereinbarung und
Befundanforderungen:
E-Mail uro-ambulanz(at)csj.de
Telefon 0941 782-3511
Fax 0941 782-3545
Sekretariat:
E-Mail urologie(at)csj.de
Telefon 0941 782-3510
Fax 0941 782-3515
